Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Day One Biopharmaceuticals, Inc. DAWN

Full chart Compare
Set alert

Price alert · DAWN

All alert types
21.53 USD 0.00 (+0.00%)

Apr 24, 2026, 9:30 AM EDT

21.53 Day range 21.53

52-week range unavailable

YTD
+131.01%
1 year
+172.53%

Financial health

Altman Z-Score

18.80 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -9.0×
FY 2019: -97.9×FY 2020: -36.2×FY 2021: -14.8×FY 2022: -10.7×FY 2023: -6.2×FY 2024: -12.4×FY 2025: -9.0×
FY 2019 5y median -10.7× FY 2025
P/S 6.1×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 9.0×FY 2025: 6.1×
FY 2019 5y median 0.0× FY 2025
P/B 2.2×
FY 2019: -136×FY 2020: 38.5×FY 2021: 3.7×FY 2022: 4.2×FY 2023: 3.4×FY 2024: 2.4×FY 2025: 2.2×
FY 2019 5y median 3.4× FY 2025
P/FCF -9.3×
FY 2019: -322×FY 2020: -107×FY 2021: -18.5×FY 2022: -12.8×FY 2023: -7.8×FY 2024: -14.8×FY 2025: -9.3×
FY 2019 5y median -12.8× FY 2025
EV/EBITDA -7.3×
FY 2019: -713999×FY 2020: 86.2×FY 2021: -10.5×FY 2022: -9.3×FY 2023: -5.0×FY 2024: -12.3×FY 2025: -7.3×
FY 2019 5y median -9.3× FY 2025
EV/Sales 4.9×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 8.1×FY 2025: 4.9×
FY 2019 5y median 0.0× FY 2025
FCF Yield -10.8%
FY 2019: -0.3%FY 2020: -0.9%FY 2021: -5.4%FY 2022: -7.8%FY 2023: -12.9%FY 2024: -6.8%FY 2025: -10.8%
FY 2019 5y median -7.8% FY 2025

Profitability

Gross Margin 89.1%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 96.0%FY 2025: 89.1%
FY 2019 5y median 0.0% FY 2025
Operating Margin -80.8%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -165.7%FY 2025: -80.8%
FY 2019 5y median 0.0% FY 2025
Net Margin -67.8%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -72.8%FY 2025: -67.8%
FY 2019 5y median 0.0% FY 2025
ROE -24.3%
FY 2019: 118.4%FY 2020: -107.3%FY 2021: -25.1%FY 2022: -42.8%FY 2023: -54.5%FY 2024: -19.0%FY 2025: -24.3%
FY 2019 5y median -25.1% FY 2025
ROIC -28.0%
FY 2019: -58.9%FY 2020: -31.4%FY 2021: -25.9%FY 2022: -44.1%FY 2023: -59.4%FY 2024: -42.7%FY 2025: -28.0%
FY 2019 5y median -42.7% FY 2025
ROA -21.1%
FY 2019: -46.2%FY 2020: -88.7%FY 2021: -24.4%FY 2022: -40.7%FY 2023: -50.2%FY 2024: -16.4%FY 2025: -21.1%
FY 2019 5y median -24.4% FY 2025

Growth (YoY)

Revenue 20.6%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 20.6%
FY 2019 FY 2025
Operating Income 41.2%
FY 2019: 0.0%FY 2020: 7.5%FY 2021: -427.8%FY 2022: -102.0%FY 2023: -40.3%FY 2024: -5.4%FY 2025: 41.2%
FY 2019 FY 2025
EPS (diluted) -2.0%
FY 2019: 0.0%FY 2020: -170.8%FY 2021: -75.4%FY 2022: -77.2%FY 2023: -17.3%FY 2024: 57.0%FY 2025: -2.0%
FY 2019 FY 2025
Free Cash Flow -29.6%
FY 2019: 0.0%FY 2020: -200.8%FY 2021: -316.3%FY 2022: -94.4%FY 2023: -36.6%FY 2024: 46.5%FY 2025: -29.6%
FY 2019 FY 2025

Financial Health

Current Ratio 8.0×
FY 2019: 13.5×FY 2020: 22.6×FY 2021: 33.4×FY 2022: 20.9×FY 2023: 12.7×FY 2024: 7.7×FY 2025: 8.0×
FY 2019 5y median 12.7× FY 2025
Quick Ratio 7.9×
FY 2019: 13.5×FY 2020: 22.6×FY 2021: 33.4×FY 2022: 20.9×FY 2023: 12.7×FY 2024: 7.6×FY 2025: 7.9×
FY 2019 5y median 12.7× FY 2025
Debt / Equity 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2019: 13666×FY 2020: -2.6×FY 2021: 3.9×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 1.4×FY 2025: 1.8×
FY 2019 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2019: -7.2×FY 2020: -459×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31